PL284343A1 - Method of obtaining a composition capable to retard replication of hiv wirus - Google Patents

Method of obtaining a composition capable to retard replication of hiv wirus

Info

Publication number
PL284343A1
PL284343A1 PL28434390A PL28434390A PL284343A1 PL 284343 A1 PL284343 A1 PL 284343A1 PL 28434390 A PL28434390 A PL 28434390A PL 28434390 A PL28434390 A PL 28434390A PL 284343 A1 PL284343 A1 PL 284343A1
Authority
PL
Poland
Prior art keywords
wirus
retard
hiv
replication
obtaining
Prior art date
Application number
PL28434390A
Other languages
English (en)
Inventor
Vera Brankovan
Richard J White
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of PL284343A1 publication Critical patent/PL284343A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PL28434390A 1989-03-17 1990-03-16 Method of obtaining a composition capable to retard replication of hiv wirus PL284343A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US40190889A 1989-09-01 1989-09-01

Publications (1)

Publication Number Publication Date
PL284343A1 true PL284343A1 (en) 1991-06-03

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
PL28434390A PL284343A1 (en) 1989-03-17 1990-03-16 Method of obtaining a composition capable to retard replication of hiv wirus

Country Status (19)

Country Link
EP (1) EP0464137A4 (de)
JP (1) JPH04504850A (de)
KR (1) KR920700653A (de)
CN (1) CN1045791A (de)
AU (1) AU5351490A (de)
CA (1) CA2050473A1 (de)
DD (1) DD301787A9 (de)
FI (1) FI914367A0 (de)
GR (1) GR1000618B (de)
HU (1) HU208254B (de)
IL (1) IL93783A0 (de)
NO (1) NO913659L (de)
NZ (1) NZ232912A (de)
OA (1) OA09555A (de)
PL (1) PL284343A1 (de)
PT (1) PT93449A (de)
WO (1) WO1990011081A1 (de)
YU (1) YU53790A (de)
ZW (1) ZW3290A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
CA2335617C (en) * 1998-06-24 2009-12-15 Novirio Pharmaceuticals Limited Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
AU2002255707A1 (en) 2001-03-15 2002-10-03 Trustees Of Boston College, The Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
EP0314011A3 (de) * 1987-10-30 1990-04-11 F. Hoffmann-La Roche Ag Purinderivate
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
GR900100189A (en) 1990-07-31
EP0464137A1 (de) 1992-01-08
HU902898D0 (en) 1991-12-30
DD301787A9 (de) 1994-01-13
YU53790A (sh) 1993-05-28
GR1000618B (el) 1992-08-31
NO913659L (no) 1991-10-18
HU208254B (en) 1993-09-28
EP0464137A4 (en) 1992-01-15
PT93449A (pt) 1990-11-07
JPH04504850A (ja) 1992-08-27
FI914367A7 (fi) 1991-09-17
KR920700653A (ko) 1992-08-10
CA2050473A1 (en) 1990-09-18
IL93783A0 (en) 1990-12-23
AU5351490A (en) 1990-10-22
CN1045791A (zh) 1990-10-03
WO1990011081A1 (en) 1990-10-04
NO913659D0 (no) 1991-09-17
OA09555A (en) 1993-01-31
NZ232912A (en) 1992-06-25
HUT57988A (en) 1992-01-28
ZW3290A1 (en) 1990-11-07
FI914367A0 (fi) 1991-09-17

Similar Documents

Publication Publication Date Title
GR880100317A (en) Process for the preparation of a composition
EG18308A (en) A process for the preparation of an antioxydant extract of spices
EP0336205A3 (en) Process for the preparation of isocyanuratepolyisocyanates, the compounds obtained according to this process and their use
IL92491A0 (en) Method of decorating a blank which is to be shaped,and the products obtained
PT80635A (en) Process for the preparation of a new galenic form with retard
HU900658D0 (en) Process for preparation of naphtaline derivatives
EG18087A (en) Derivatives of hydroxy-4-2h-1-1 benzothiopyran-2-and their preparation and use as rodenticide
GB2220386B (en) Method of making a diffractive composition
CS900788A2 (en) Method of substituted styrene derivatives preparation
PT85880A (en) Process for preparing a retarded release pharmaceutical composition
PL284343A1 (en) Method of obtaining a composition capable to retard replication of hiv wirus
EP0328754A3 (en) Method of forming shaped-body to be sintered
ZA885264B (en) Preparation of a new diosmine derivative
EG18954A (en) New bronchospasmolytic compounds and process for their preparation
EP0290817A3 (en) A use of oxetanocin for inhibiting hiv
GB2228482B (en) Preparation of alpha-alkylidene lactones
GB8727716D0 (en) Preparation of alkanolamine derivatives
GB2180835B (en) A method for the preparation of sodium and magnesium stearate
PH24774A (en) Preparation of a peperidinylcyclopenthylheptenoic
GR900100781A (en) Preparation process of selenophen derivatives
GB8909397D0 (en) Process for the preparation of a furan derivative
GB8720773D0 (en) Preparation of derivatives
GR880100685A (en) Preparation method of new analogue nucleozites
GB2164647B (en) Process for the preparation of a furan derivative
ZA84719B (en) Derivatives of 3-pyrrolidinopropiophenone and a process for preparation thereof